Hepatic Arterial Infusion Chemotherapy in Patients With Inoperable Colorectal Cancer Liver Metastasis

Hepatic Arterial Infusion Chemotherapy in Patients With Inoperable Colorectal Cancer Liver Metastasis is a phase 2, interventional study registered as NCT07764497 by Sunnybrook Health Sciences Centre, with a registry enrolment figure of 200 participants, started 2014-07 and due to reach its primary completion in 2036-12. Interventions recorded: Floxuridine (FUDR). Conditions listed: Colorectal Adenocarcinoma Metastatic in the Liver; Liver Metastasis Colon Cancer; Liver Metastases From Colorectal Cancer; Liver Metastases of Colorectal Cancer. Primary outcome: Proportion of participants that undergo liver resection following treatment with FUDR. Colorectal eligibility wording from the registry: "History of histologically confirmed colorectal adenocarcinoma metastatic to the liver with no clinical or radiographic evidence of extrahepatic disease". Sites: Canada. No results are recorded here; the registry entry is the source.